Romeo G, Salerno L, Milla P, Siracusa M, Cattel L, Russo F
Dipartimento di Scienze Farmaceutiche, Università di Catania, Italy.
Pharmazie. 1999 Jan;54(1):19-23.
Several novel N-(4,5-diphenylthiazol-2-yl)-N'-aryl or alkyl (thio)ureas and N-(4,5-diphenylthiazol-2-yl)alkanamides were prepared as potential acyl-CoA: cholesterol O-acyltransferase (ACAT) inhibitors. Synthesis was accomplished by reaction of 2-amino-4,5-diphenylthiazole with the suitable isocyanate, isothiocyanate or acyl chloride. Some analogues without the 5-phenyl substituent or both the phenyl groups in 4 and 5 position of the thiazole ring were also prepared. Moreover, some bioisosters of the title compounds in which the thiazole ring was replaced by an imidazole were synthesized starting from the 2-amino-4,5-diphenyl-1H-imidazole. The ability of synthesized compounds to inhibit ACAT was evaluated in vitro by measuring the formation of cholesteryl[14C]oleate from cholesterol and [1-14C]oleoyl-CoA in rat liver microsomes. Among the tested compounds, only some thiazole ureas were able to inhibit ACAT in a reasonable degree. N-(4,5-diphenylthiazol-2-yl)- N'-[2,6-bis(2-methylethyl)phenyl] urea (11) and N-(4,5-diphenylthiazol-2-yl)-N'-n-butyl urea (16) were the most active compounds in the series showing IC50 values in the low micromolar range.
制备了几种新型的N-(4,5-二苯基噻唑-2-基)-N'-芳基或烷基(硫代)脲以及N-(4,5-二苯基噻唑-2-基)链烷酰胺,作为潜在的酰基辅酶A:胆固醇O-酰基转移酶(ACAT)抑制剂。通过2-氨基-4,5-二苯基噻唑与合适的异氰酸酯、异硫氰酸酯或酰氯反应来完成合成。还制备了一些在噻唑环的5-位没有苯基取代基或4和5位都没有苯基的类似物。此外,从2-氨基-4,5-二苯基-1H-咪唑开始合成了一些标题化合物的生物电子等排体,其中噻唑环被咪唑取代。通过测量大鼠肝微粒体中胆固醇和[1-14C]油酰辅酶A形成胆固醇[14C]油酸酯的情况,在体外评估了合成化合物抑制ACAT的能力。在测试的化合物中,只有一些噻唑脲能够在合理程度上抑制ACAT。N-(4,5-二苯基噻唑-2-基)-N'-[2,6-双(2-甲基乙基)苯基]脲(11)和N-(4,5-二苯基噻唑-2-基)-N'-正丁基脲(16)是该系列中活性最高的化合物,IC50值在低微摩尔范围内。